CEConversations
by Creative Educational Concepts
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·43 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
A CaseWise™ Webcast: From Research to Real-World: ADCs, IO Combinations, and Sequencing in Metastatic NSCLC
Jul 1, 2026
1h 07m 45s
Exploring the Horizons in Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions for New Treatment Strategies
Jul 1, 2026
1h 04m 47s
Evolving Paradigms in Immuno-Oncology: Optimizing Patient Care Through Innovative Delivery Approaches of Immune Checkpoint Inhibitors
Jul 1, 2026
32m 12s
Targeting the Pathway: Evolving Roles of MEK Inhibitors in NF1-Associated PN
Jul 1, 2026
1h 04m 25s
The New Era of Hemophilia Treatment
Jan 28, 2026
45m 41s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/1/26 | precision oncologycancer care+5 | — | Antibody-drug conjugates (ADCs)Creative Educational Concepts+1 | metastatic non-small cell lung cancer (mNSCLC) | ADCsprecision oncology+5 | — | 1h 07m 45s | ||
| 7/1/26 | endometrial cancertreatment strategies+4 | — | Creative Educational Conceptsadvanced or recurrent endometrial cancer+3 | — | endometrial cancertreatment+4 | — | 1h 04m 47s | ||
| 7/1/26 | immuno-oncologypatient care+4 | — | Immune checkpoint inhibitorsSubcutaneous administration+2 | — | immuno-oncologyimmune checkpoint inhibitors+4 | — | 32m 12s | ||
| 7/1/26 | neurofibromatosisMEK inhibitors+3 | — | Neurofibromatosis type 1NF1+2 | — | neurofibromatosisMEK inhibitors+3 | — | 1h 04m 25s | ||
| 1/28/26 | hemophilia treatmentshared decision making+4 | — | non‑factor optionshigh‑sustained factor products+4 | — | hemophiliatreatment options+5 | — | 45m 41s | ||
| 10/1/25 | Neurofibromatosisnursing contributions+3 | — | Neurofibromatosis type 1plexiform neurofibromas | — | NeurofibromatosisNF1+5 | — | 1h 04m 33s | ||
| 9/19/25 | desmoid tumorsearly recognition+4 | — | tyrosine kinase inhibitorsgamma-secretase inhibitors+1 | — | desmoid tumorsnursing+4 | — | 54m 51s | ||
| 9/19/25 | neurofibromatosistherapeutic advances+3 | — | mitogen-activated protein kinase inhibitorsCreative Educational Concepts+2 | — | neurofibromatosisplexiform neurofibroma+3 | — | 1h 32m 45s | ||
| 8/28/25 | immunotherapyemergency medicine+3 | — | CAR T-cellBispecific Antibody Immunotherapies+1 | — | immunotherapyCAR T-cell+4 | — | 47m 28s | ||
| 7/10/25 | oncology nursingbreast cancer+4 | — | Creative Educational ConceptsADC+1 | HER2-negativeMBC | HER2-negativebreast cancer+5 | — | 49m 37s |
Showing 10 of 10
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.